In this study, we revealed that elevated anti-GAPDH was positively associated with increased intracranial pressure and cerebrovascular lesion onset; however, significantly lower incidence of seizure disorders was observed in patients with a higher anti-GAPDH, which implicated the complex and differential pathological roles of autoantibodies in SLE development. Here, GAPDH is linked to systemic lupus erythematosus.